At DNA Medicine Institute, we are committed to transforming global health with technologies that are faster, smarter, and accessible to all. Our research pushes beyond conventional limits to create powerful medical tools that can be deployed anywhere in the world — even in the most resource-limited environments.

rHEALTH receives NIH support to advance fingertip-based diagnostics for Hemophilia A, enabling rapid, accessible testing of FVIII and emicizumab levels worldwide — from clinics to remote, underserved regions.

A major milestone in space medicine — NASA has deployed DMI’s rHEALTH ONE blood analyzer aboard the International Space Station, bringing rapid, autonomous diagnostics one step closer to supporting long-duration spaceflight and delivering transformative healthcare benefits for Earth.